Covid19, Inflammatory Disease
Conditions
Brief summary
This questionnaire is distributed via a mailing list (e-mail) of patients treated within the framework of the FHU for pathologies including chronic inflammatory bowel diseases or IBD (Crohn's disease and ulcerative colitis), inflammatory rheumatic diseases (such as rheumatoid arthritis and ankylosing spondylitis), but also asthma, psoriasis, atopic dermatitis as well as systemic autoimmune (such as scleroderma, lupus, angioedema) and neurological (multiple sclerosis) diseases. A two-step analysis will be conducted: impact of lock down(March 17, 2020 - May 11, 2020) and a 2-month assessment of end of lock down (from May 11, 2020) on issues addressing: overall impact, impact on the disease, treatment and follow-up, and access to information related to the epidemic during these periods.
Interventions
None listed
Sponsors
University Hospital, Lille
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
patient followed for : * Chronic inflammatory bowel disease or IBD (Crohn's disease and ulcerative colitis), * Inflammatory rheumatism (rheumatoid arthritis and spondylitis) * Multiple Sclerosis * Asthma * Psoriasis * Atopic Dermatitis * Systemic autoimmune diseases (scleroderma and lupus)
Exclusion criteria
* Minor patient * Patient cannot read or write * Patient without computer equipment * Patient with no internet access * Patient not having filled in his e-mail in his file * Patient does not wish to be contacted by email
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The answer will be considered positive if the patient answers totally agree, or agree, or slightly agree, or neither agree nor disagree. | At 2 months | The answer to question 13 of the lock down questionnaire: Do you feel that you have been less well followed by your medical specialist compared to the pre-lock down period? |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Proportion of patients (in percentage and numbers) whose response is considered positive if the patient answered Slightly agree, Agree or Totally agree to question 9 of the lock down questionnaire | At 2 months | — |
| Proportion of patients (in percentage and numbers) whose response is considered positive if the patient answered yes to question 34 of the lock down questionnaire | At 2 months | — |
| Proportion of patients (in percentage and numbers) whose response is considered positive if the patient answered Slightly agree or Agree or Strongly agree to question 38 of the lock down questionnaire | At 2 months | — |
| Proportion of patients (in percentages and numbers) whose response will be considered positive to questions 13 and 14 of the lock down questionnaire and comparison between the different specialities filled in in question 3. | At 2 months | Proportion of patients (in percentages and numbers) whose response will be considered positive if the patient answers totally agree, or agree, or slightly agree, or neither agree nor disagree to questions 13 and 14 of the lock down questionnaire and comparison between the different specialities filled in in question 3. |
| Proportion of patients (in percent and numbers) whose response will be considered positive to questions 9, 13, 14, 38 or Yes to question 34 of the end of lock down and lock down Evaluation Questionnaire. | At 2 months | Proportion of patients (in percent and numbers) whose response will be considered positive if the patient answers Slightly agree, Agree or Strongly agree to questions 9, 13, 14, 38 or Yes to question 34 of the end of lock down and lock down Evaluation Questionnaire. |
Countries
France
Outcome results
None listed